β2-agonists, which are a common asthma treatment, can increase BPIFA1 expression33, whereas our data suggest that the short-term β2-agonist albuterol only enhances BPIFA1 secretion (Supplementary Fig. 4). The gene discussed is BPIFA1; the disease is asthma.